The invention provides methods of treating neoplasia using combinations of target
cell-specific replication competent adenoviral vectors and chemotherapy, radiation
therapy or combinations thereof. The adenoviral vectors are target cell-specific
for the particular type of neoplasia for which treatment is necessary and the combination
with the chemotherapy and/or radiation leads to synergistic treatment over existing
adenoviral therapy or traditional chemotherapy and radiation therapy.
